These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36669790)

  • 21. Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model.
    Vulih-Shultzman I; Pinhasov A; Mandel S; Grigoriadis N; Touloumi O; Pittel Z; Gozes I
    J Pharmacol Exp Ther; 2007 Nov; 323(2):438-49. PubMed ID: 17720885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-cell analysis of cytoskeleton dynamics: From isoelectric focusing to live cell imaging and RNA-seq.
    Gozes I; Ivashko-Pachima Y; Kapitansky O; Sayas CL; Iram T
    J Neurosci Methods; 2019 Jul; 323():119-124. PubMed ID: 31150696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate.
    Gozes I
    Peptides; 2011 Feb; 32(2):428-31. PubMed ID: 21050875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.
    Ivashko-Pachima Y; Maor-Nof M; Gozes I
    PLoS One; 2019; 14(3):e0213666. PubMed ID: 30865715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introducing ADNP and SIRT1 as new partners regulating microtubules and histone methylation.
    Hadar A; Kapitansky O; Ganaiem M; Sragovich S; Lobyntseva A; Giladi E; Yeheskel A; Avitan A; Vatine GD; Gurwitz D; Ivashko-Pachima Y; Gozes I
    Mol Psychiatry; 2021 Nov; 26(11):6550-6561. PubMed ID: 33967268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct Impairments Characterizing Different ADNP Mutants Reveal Aberrant Cytoplasmic-Nuclear Crosstalk.
    Ganaiem M; Karmon G; Ivashko-Pachima Y; Gozes I
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury.
    Gozes I; Zaltzman R; Hauser J; Brenneman DE; Shohami E; Hill JM
    Curr Alzheimer Res; 2005 Apr; 2(2):149-53. PubMed ID: 15974912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal Genotype-Phenotype (Vineland Questionnaire) Characterization of 15 ADNP Syndrome Cases Highlights Mutated Protein Length and Structural Characteristics Correlation with Communicative Abilities Accentuated in Males.
    Levine J; Lobyntseva A; Shazman S; Hakim F; Gozes I
    J Mol Neurosci; 2024 Jan; 74(1):15. PubMed ID: 38282129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-SAL and NAP: Two Peptides Sharing a SIP Domain.
    Gozes I; Sragovich S; Schirer Y; Idan-Feldman A
    J Mol Neurosci; 2016 Jun; 59(2):220-31. PubMed ID: 26816081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: mutated ADNP cytoskeletal impairments and repair as a case study.
    Ivashko-Pachima Y; Hadar A; Grigg I; Korenková V; Kapitansky O; Karmon G; Gershovits M; Sayas CL; Kooy RF; Attems J; Gurwitz D; Gozes I
    Mol Psychiatry; 2021 May; 26(5):1619-1633. PubMed ID: 31664177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy.
    Jouroukhin Y; Ostritsky R; Gozes I
    J Mol Neurosci; 2012 Nov; 48(3):597-602. PubMed ID: 22956189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP).
    Magen I; Gozes I
    Neuropeptides; 2013 Dec; 47(6):489-95. PubMed ID: 24210139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP.
    Van Dijck A; Vulto-van Silfhout AT; Cappuyns E; van der Werf IM; Mancini GM; Tzschach A; Bernier R; Gozes I; Eichler EE; Romano C; Lindstrand A; Nordgren A; ; Kvarnung M; Kleefstra T; de Vries BBA; Küry S; Rosenfeld JA; Meuwissen ME; Vandeweyer G; Kooy RF
    Biol Psychiatry; 2019 Feb; 85(4):287-297. PubMed ID: 29724491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosis.
    Braitch M; Kawabe K; Nyirenda M; Gilles LJ; Robins RA; Gran B; Murphy S; Showe L; Constantinescu CS
    Neuroimmunomodulation; 2010; 17(2):120-5. PubMed ID: 19923857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADNP/ADNP2 expression in oligodendrocytes: implication for myelin-related neurodevelopment.
    Malishkevich A; Leyk J; Goldbaum O; Richter-Landsberg C; Gozes I
    J Mol Neurosci; 2015 Oct; 57(2):304-13. PubMed ID: 26315608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity-dependent neuroprotective protein: from gene to drug candidate.
    Gozes I
    Pharmacol Ther; 2007 May; 114(2):146-54. PubMed ID: 17363064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel tubulin and tau neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide).
    Gozes I; Iram T; Maryanovsky E; Arviv C; Rozenberg L; Schirer Y; Giladi E; Furman-Assaf S
    J Alzheimers Dis; 2014; 40 Suppl 1():S23-36. PubMed ID: 24503616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VIP/PACAP-Based Drug Development: The ADNP/NAP-Derived Mirror Peptides SKIP and D-SKIP Exhibit Distinctive
    Sragovich S; Amram N; Yeheskel A; Gozes I
    Front Cell Neurosci; 2019; 13():589. PubMed ID: 31992971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADNP Plays a Key Role in Autophagy: From Autism to Schizophrenia and Alzheimer's Disease.
    Sragovich S; Merenlender-Wagner A; Gozes I
    Bioessays; 2017 Nov; 39(11):. PubMed ID: 28940660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.
    Amram N; Hacohen-Kleiman G; Sragovich S; Malishkevich A; Katz J; Touloumi O; Lagoudaki R; Grigoriadis NC; Giladi E; Yeheskel A; Pasmanik-Chor M; Jouroukhin Y; Gozes I
    Mol Psychiatry; 2016 Oct; 21(10):1467-76. PubMed ID: 26782054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.